Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2791211 | 0.81 | PDK2 (0.34) | PDK2 | |
| SCHEMBL4248046 | 0.80 | PDK2 (0.33) | PDK2 | |
| SCHEMBL12761337 | 0.79 | JAK2 (0.33) | — | |
| SCHEMBL13726356 | 0.79 | JAK2 (0.33) | — | |
| SCHEMBL16489399 | 0.79 | PDK2 (0.36) | PDK2 | |
| SCHEMBL29458875 | 0.77 | PDK2 (0.42) | PDK2 | |
| SCHEMBL5013191 | 0.77 | PDK2 (0.42) | PDK2 | |
| SCHEMBL5063493 | 0.77 | PDK2 (0.42) | PDK2 | |
| SCHEMBL29294792 | 0.77 | PDK2 (0.42) | PDK2 | |
| SCHEMBL29403081 | 0.77 | PDK2 (0.44) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014104666-A1 | INK COMPOSITION FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT USING SAME | 주식회사 두산 (KR) | 2014-07-03 | — | — | WO | disclosed |
| US-8395144-B2 | Anthracene derivatives and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2013-03-12 | — | — | US | disclosed |
| US-8395144-B2 | Anthracene derivatives and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2013-03-12 | — | — | US | disclosed |
| US-20110057182-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2011-03-10 | — | — | US | disclosed |
| US-20110057182-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2011-03-10 | — | — | US | disclosed |
| WO-2009139580-A2 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 주식회사 두산 (KR) | 2009-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110057182-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | TRPA1, AHR, ORAI2 | PDK2 836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.